Supplemental recommendations for the use of intranasally administered trivalent live attenuated influenza virus vaccine [`FluMist'] have been released by the ACIP,

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.434, 2003-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Live Attenuated Influenza Vaccine (FluMist®; Fluenz™): A Review of its Use in the Prevention of Seasonal Influenza in Children and Adults

By Carter Natalie J.   Curran Monique P.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1591-1622

Adis International

Access to resources Recommend Favorite

ACIP recommendations for flu vaccine use during US shortage

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 325, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Influenza Virus Vaccine Live Intranasal -Aviron: Flumist™, Influenza Vaccine Live Intranasal

By  

Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. : 123-129

Adis International

Access to resources Recommend Favorite

Live Attenuated Influenza Vaccine (Fluenz™): A Guide to its Use in the Prevention of Seasonal Influenza in Children in the EU

By Scott Lesley J.   Carter Natalie J.   Curran Monique P.  

Pediatric Drugs, Vol. 14, Iss. 4, 2012-08 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

The US CDC's Advisory Committee on Immunization Practices (ACIP) has released updated recommendations for the prevention and control of influenza.

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite